PE20000172A1 - Procedimiento e intermedios para preparar naftiridonas - Google Patents

Procedimiento e intermedios para preparar naftiridonas

Info

Publication number
PE20000172A1
PE20000172A1 PE1999000022A PE00002299A PE20000172A1 PE 20000172 A1 PE20000172 A1 PE 20000172A1 PE 1999000022 A PE1999000022 A PE 1999000022A PE 00002299 A PE00002299 A PE 00002299A PE 20000172 A1 PE20000172 A1 PE 20000172A1
Authority
PE
Peru
Prior art keywords
formula
procedure
compound
alkyl
refers
Prior art date
Application number
PE1999000022A
Other languages
English (en)
Inventor
Charles Kwok-Funk Chiu
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20000172A1 publication Critical patent/PE20000172A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO PARA PREPARAR UN ACIDO NAFTIRIDONA CARBOXILICO TAL COMO TROVAFLOXACINA DE FORMULA VII UTILIZANDO UN INTERMEDIO DE FORMULA I DONDE R1 ES BENCILO, OPCIONALMENTE SUSTITUIDO POR ALQUILO C1-C6, ALCOXI C1-C6, HALOGENO, NITRO, AMINO, TRIFLUOROMETILO; R2 ES ALQUILO C1-C6, TRIFLUOROMETILO, FENILO OPCIONALMENTE SUSTITUIDO POR ALQUILO C1-C6, ALCOXI C1-C6, HALOGENO, NITRO, AMINO, TRIFLUOROMETILO; EL INTERMEDIO I SE PREPARA AL a)REDUCIR UN COMPUESTO DE FORMULA II, EN PRESENCIA DE HIERRO Y UN DISOLVENTE ORGANICO EN CONDICIONES ACIDAS; b)ACILAR EL COMPUESTO FORMADO CON UN AGENTE DE ACILACION DE FORMULA R2C(O)X; X ES UN GRUPO SALIENTE. TAMBIEN SE REFIERE A UN PROCEDIMIENTO EN EL QUE EL COMPUESTO I SE SOMETE A DESBENCILACION, POR REACCION CON HIDROGENO, UN CATALIZADOR DE PALADIO EN ACIDO ACETICO Y UN DISOLVENTE ORGANICO PARA FORMAR EL COMPUESTO DE FORMULA IV. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE FORMULA VII. LA TROVAFLOXACINA PUEDE SER UTIL EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS CAUSADAS POR CEPAS GRAM POSITIVAS
PE1999000022A 1998-01-16 1999-01-11 Procedimiento e intermedios para preparar naftiridonas PE20000172A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7160198P 1998-01-16 1998-01-16

Publications (1)

Publication Number Publication Date
PE20000172A1 true PE20000172A1 (es) 2000-03-09

Family

ID=22102373

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000022A PE20000172A1 (es) 1998-01-16 1999-01-11 Procedimiento e intermedios para preparar naftiridonas

Country Status (39)

Country Link
EP (1) EP0930297B1 (es)
JP (1) JPH11255745A (es)
KR (1) KR19990067905A (es)
CN (1) CN1228422A (es)
AP (1) AP9901440A0 (es)
AR (1) AR017228A1 (es)
AT (1) ATE238281T1 (es)
AU (1) AU9711598A (es)
BG (1) BG64094B1 (es)
BR (1) BR9900066A (es)
CA (1) CA2258960C (es)
DE (1) DE69907042T2 (es)
DK (1) DK0930297T3 (es)
EA (1) EA199900020A3 (es)
EG (1) EG21514A (es)
ES (1) ES2195513T3 (es)
GT (1) GT199800199A (es)
HR (1) HRP990013A2 (es)
HU (1) HUP9900121A3 (es)
ID (1) ID23612A (es)
IL (1) IL127945A0 (es)
IS (1) IS4943A (es)
MA (1) MA24745A1 (es)
NO (1) NO990185L (es)
NZ (1) NZ333769A (es)
OA (1) OA10955A (es)
PA (1) PA8464701A1 (es)
PE (1) PE20000172A1 (es)
PL (1) PL330859A1 (es)
PT (1) PT930297E (es)
SA (1) SA99190971A (es)
SG (1) SG76584A1 (es)
SI (1) SI0930297T1 (es)
SK (1) SK3899A3 (es)
TN (1) TNSN99005A1 (es)
TR (1) TR199900070A2 (es)
TW (1) TW483890B (es)
YU (1) YU1799A (es)
ZA (1) ZA99277B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2049777C1 (ru) * 1989-08-16 1995-12-10 Пфайзер Инк. Азабицикло-хинолон-карбоновые кислоты или их фармацевтически приемлемые кислотно-аддитивные соли и промежуточные продукты для их получения
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) * 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
US5475116A (en) * 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
DE19733439A1 (de) * 1997-08-02 1999-02-04 Bayer Ag Neue 6-endo-Amino-3-azabicyclo(3.1.0)hexande, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Chinolon- und Naphthyridincarbonsäure-Derviaten mit verbesserten Eigenschaften

Also Published As

Publication number Publication date
AP9901440A0 (en) 1999-03-31
EA199900020A2 (ru) 1999-08-26
ZA99277B (en) 2000-07-17
BG103087A (en) 1999-08-31
PT930297E (pt) 2003-08-29
SI0930297T1 (en) 2003-08-31
HUP9900121A3 (en) 2000-02-28
TNSN99005A1 (fr) 2005-11-10
HUP9900121A2 (hu) 1999-09-28
DE69907042T2 (de) 2003-10-16
HU9900121D0 (en) 1999-03-29
IL127945A0 (en) 1999-11-30
SK3899A3 (en) 2000-03-13
CA2258960C (en) 2002-09-03
ID23612A (id) 2000-05-04
CA2258960A1 (en) 1999-07-16
EP0930297A1 (en) 1999-07-21
YU1799A (sh) 2000-03-21
ES2195513T3 (es) 2003-12-01
PL330859A1 (en) 1999-07-19
BG64094B1 (bg) 2003-12-31
AR017228A1 (es) 2001-08-22
OA10955A (en) 2001-10-31
EA199900020A3 (ru) 1999-12-29
HRP990013A2 (en) 1999-10-31
MA24745A1 (fr) 1999-10-01
JPH11255745A (ja) 1999-09-21
DK0930297T3 (da) 2003-07-21
AU9711598A (en) 1999-08-05
GT199800199A (es) 2000-06-07
TW483890B (en) 2002-04-21
BR9900066A (pt) 2000-05-09
EP0930297B1 (en) 2003-04-23
NZ333769A (en) 2000-03-27
NO990185L (no) 1999-07-19
CN1228422A (zh) 1999-09-15
TR199900070A3 (tr) 1999-10-21
DE69907042D1 (de) 2003-05-28
KR19990067905A (ko) 1999-08-25
IS4943A (is) 1999-07-17
TR199900070A2 (xx) 1999-10-21
ATE238281T1 (de) 2003-05-15
EG21514A (en) 2001-11-28
PA8464701A1 (es) 2000-09-29
SG76584A1 (en) 2000-11-21
SA99190971A (ar) 2005-12-03
NO990185D0 (no) 1999-01-15

Similar Documents

Publication Publication Date Title
NO20180010A1 (no) Forløperforbindelse for radioaktive, halogenmerkede organiske forbindelser
DE3770095D1 (de) Chinazolindione und pyridopyrimidindione.
DK1222173T3 (da) Fremgangsmåde til fremstilling af 4-trifluormethylsulphinylpyrazolderivat
AR079237A2 (es) Proceso para la preparacion de derivados de dibenzo(b,f) azepina
HUP9903836A2 (hu) Új eljárás Cox-2 inhibítor hatású fenil-szubsztituált 2(5H)-furanonok előállítására
BRPI0408160B1 (pt) Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo
AU2002356860A1 (en) Preparation of amphetamines from phenylpropanolamines
PE20000477A1 (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo[4.3.0)nonano
PE20000172A1 (es) Procedimiento e intermedios para preparar naftiridonas
PE20030929A1 (es) Acidos 3-(imidazolil)-2-alcoxipropanoicos
BR0009453B1 (pt) processo para a preparação de um composto.
AU1998701A (en) Process for the preparation of ketimines
BR9912561A (pt) Processo aperfeiçoado para o preparo de n-óxido 2-halopiridina
IL169073A (en) Process for the preparation of pregnanes
PT1143962E (pt) Solucao parenterica de propofol (2,6-di-isopropilfenol) e 2,5-di-o-metil-1,4;3,6-di-anidro-d-glucitol, como dissolvente
AR029004A1 (es) Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
PE20020551A1 (es) Proceso para preparar derivados de distamicina
ES2055321T3 (es) Preparacion de derivados de acido glutarico.
DE60007848D1 (de) Herstellung von 2'-substitutierter rns
BR0111656A (pt) Processos para a preparação de compostos pesticidas e composto inovadores
ES2136028A1 (es) Esteres del acido 2-(r)-fluorosulfoniloxi-4-fenibutirico, procedimiento para su obtencion y procedimiento para su utilizacion en la preparacion de carboxialquildipeptidos.
EP0792936A3 (en) Process for the preparation of optically active 2-halo-1-(substituted phenyl) ethanol
PL1654209T3 (pl) Sposób wytwarzania składnika kosmetycznie aktywnego
KR920012048A (ko) 퀴녹살리닐옥시페녹시프로피온산의 광학적 활성 에스테르의 제조방법
DE60300057D1 (de) Verfahren zur Herstellung von Ether-Verbindungen als Insektizide und/oder Akarizide und Zwischenprodukte dazu

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed